脑血管随机对照试验的可重复性评估
该研究回顾2000至2018年脑血管领域随机对照试验,计算脆弱指数并提出基于脆弱指数的新型分类系统。共纳入20项主要结局组间差异显著的RCT,中位脆弱指数为5.5,另加30项随机选取的RCT用于建立高可靠性分类系统。作者建议神经外科医生和神经介入医生谨慎解读脑血管RCT结果,尤其当样本量小、事件数少且失访患者多时。
要点
- 脑血管RCT中位脆弱指数仅5.5,结果稳健性有限。
- 失访患者数与脆弱指数之差同脆弱商呈负相关,可用于分级。
- 样本量小、事件少且失访多时,应谨慎解读RCT结论。
核心结论
- 神经外科医生和神经介入医生应谨慎解读脑血管RCT结果,尤其当样本量小、事件数少且失访患者多时。
研究设计与样本
- 回顾性分析2000至2018年发表的脑血管RCT,聚焦卒中、颈动脉狭窄、脑动脉瘤和蛛网膜下腔出血六个关键领域。
- 共纳入20项主要结局组间差异显著的RCT,另随机选取30项RCT用于建立分类系统。
主要发现
- 20项RCT的中位脆弱指数为5.5。
- 失访患者数与脆弱指数之差同脆弱商呈负相关,并据此将RCT稳健性分为3类。
关键数值与推荐
- 中位脆弱指数为5.5(20项主要结局显著的脑血管RCT)。
- 基于失访患者数与脆弱指数之差同脆弱商的负相关关系,将RCT稳健性分为3类。
临床怎么用
- 临床解读脑血管RCT时,应结合脆弱指数、样本量、事件数和失访人数综合判断结论可靠性。
- 可参考本文提出的3类稳健性分类系统评估RCT可重复性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Numerous randomized controlled trials (RCTs) relevant to the cerebrovascular field have been performed. The fragility index was recently developed to complement the P value and measure the robustness and reproducibility of clinical findings of RCTs. OBJECTIVE: In this study, we evaluate the fragility index for key surgical and endovascular cerebrovascular RCTs and propose a novel RCT classification system based on the fragility index. METHODS: Cerebrovascular RCTs reported between 2000 and 2018 were reviewed. Six key areas were specifically targeted in relation to stroke, carotid stenosis, cerebral aneurysms, and subarachnoid hemorrhage. The correlation between fragility index, number of patients lost to follow-up, and fragility quotient were evaluated to propose a classification system for the robustness of the studies. RESULTS: A total of 20 RCTs that reported significant differences between both study groups in terms of the primary outcome were included. The median fragility index for the trials was 5.5. An additional 30 randomly selected RCTs were added to propose a classification system with high reliability. The difference between the number of patients lost to follow-up and fragility index inversely correlated with the fragility quotient and was used to divide the robustness of the RCTs into 3 classes reflecting the reproducibility of the trial. CONCLUSIONS: Neurosurgeons and neurointerventionalists should exercise caution with interpreting the results of cerebrovascular RCTs, especially when the sample size and events numbers are small and there is a high number of patients who were lost to follow-up, as quantitatively identified using the proposed classification system.
引用
- Adeeb N, Terrell DL, Whipple SG, et al. The Reproducibility of Cerebrovascular Randomized Controlled Trials. World Neurosurg. 2020. PMID: 32437984. doi:10.1016/j.wneu.2020.04.106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。